Jones Financial Companies
BMRN icon

Jones Financial Companies’s BioMarin Pharmaceuticals BMRN Stock Holding History

Jones Financial Companies’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
5,292
+3,060
+137% +$178K ﹤0.01% 2261
2025
Q4 		$133K Buy
2,232
+831
+59% +$45.2K ﹤0.01% 2105
2025
Q3 		$75.4K Buy
1,401
+656
+88% +$37.5K ﹤0.01% 2195
2025
Q2 		$41.1K Buy
745
+138
+23% +$8.13K ﹤0.01% 2301
2025
Q1 		$43.4K Buy
607
+242
+66% +$16.3K ﹤0.01% 2122
2024
Q4 		$24K Buy
365
+260
+248% +$17.4K ﹤0.01% 2174
2024
Q3 		$7.41K Buy
105
+20
+24% +$1.67K ﹤0.01% 2325
2024
Q2 		$7K Buy
+85
New +$7.08K ﹤0.01% 1865
2024
Q1 		– Sell
-450
Closed -$43.4K – 1372
2023
Q4 		$43.4K Buy
+450
New +$39.8K ﹤0.01% 494
2021
Q2 		– Sell
-17
Closed -$1K – 642
2021
Q1 		$1K Sell
17
-70
-80% -$5.72K ﹤0.01% 763
2020
Q4 		$8K Buy
+87
New +$6.9K ﹤0.01% 450
2013
Q3 		– Sell
-115
Closed -$6K – 724
2013
Q2 		$6K Buy
+115
New +$7.17K ﹤0.01% 661

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's BMRN Position: Q1 2026 in Review

Jones Financial Companies increased its BioMarin Pharmaceuticals (BMRN) stake by 137% in Q1 2026, buying an estimated $178K and bringing the position to 5,292 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

Jones Financial Companies first reported a position in BMRN in Q2 2013 and has held it in 12 quarters since. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Jones Financial Companies held 5,292 shares of BioMarin Pharmaceuticals worth $287K as of Q1 2026.
  • Jones Financial Companies bought 3,060 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $178K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2261 holding.
  • Jones Financial Companies first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
  • 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.